Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Mesothelin-positive Advanced Refractory Solid Tumors × Cyclophosphamide × 30 days × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Multiple Myeloma 19 Lymphoma, Large B-Cell, Diffuse 18 Burkitt Lymphoma 17 Lymphoma 15 Lymphoma, Follicular 14 Neoplasms 13 Leukemia, Myeloid, Acute 12 Leukemia, Lymphocytic, Chronic, B-Cell 12 Recurrence 10 Lymphoma, Non-Hodgkin 10 Breast Neoplasms 10 Myelodysplastic Syndromes 8 Melanoma 8 Hodgkin Disease 8 Lymphoma, B-Cell, Marginal Zone 7 Leukemia, Biphenotypic, Acute 7 Leukemia 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Lymphoma, B-Cell 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Sarcoma 5 Rhabdomyosarcoma 5 Ovarian Neoplasms 5 Lymphoma, Mantle-Cell 5 Sarcoma, Ewing 4 Pancreatic Neoplasms 4 Neuroblastoma 4 Neoplasm Metastasis 4 Immunoglobulin Light-chain Amyloidosis 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡